Trial Profile
A Phase 3 Multi-centre Randomised Placebo-controlled Study of Azithromycin in the Primary Prevention of Radiologically-defined Bronchiectasis in Infants With Cystic Fibrosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Sep 2021
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Bacterial infections; Bronchiectasis; Cystic fibrosis
- Focus Therapeutic Use
- Acronyms COMBATCF
- 08 Sep 2021 Status changed from active, no longer recruiting to completed.
- 27 Nov 2019 Planned End Date changed from 1 Dec 2020 to 1 May 2021.
- 27 Nov 2019 Status changed from recruiting to active, no longer recruiting.